Previous studies using in vivo disease models have shown that IL-33 exacerbates allergic inflammation 18 but confers resistance to parasite infection 19 and attenuates atherosclerosis 20 through inducing type 2 immune responses. This evidence concerns the gene IL33 and atherosclerosis.